Generated by AI
iRadimed Corporation is a medical device company that develops, manufactures, markets, and distributes MRI-compatible patient care solutions. Its product portfolio includes MRI-compatible intravenous infusion pump systems, patient vital signs monitoring systems, ferromagnetic detection devices, and related accessories and disposables designed for use in magnetic resonance imaging environments. The company’s products are used by hospitals, acute care facilities, and outpatient imaging centers to support patient monitoring and medication delivery during MRI procedures. iRadimed Corporation focuses on equipment engineered with non-magnetic components to help maintain clinical workflow and patient safety in high-field imaging settings. Headquartered in Orlando, Florida, iRadimed Corporation serves customers in the United States and internationally through a specialized medical technology platform centered on MRI-compatible care.
Website12705 Ingenuity Drive
Orlando, FL, 32826
United States
The latest articles about IRMD.
IRADIMED reported third quarter 2026 sales of US$24.2 million and net income of US$6.51 million, alongside confirming a regular US$0.20 per share cash dividend payable on November 27, 2026 to shareholders of record on November 13, 2026. The mix of higher quarterly earnings per share, positive fourth quarter and full year 2026 guidance, and a maintained dividend indicates that IRADIMED is currently balancing product momentum with ongoing cash returns to shareholders. This article will examine...
IRADIMED guidance, earnings and dividend in focus IRADIMED (IRMD) moved into the spotlight after releasing third quarter 2026 results, issuing fresh guidance for the fourth quarter and full year, and reaffirming its regular quarterly dividend. IRADIMED shares trade at $79.42 after a 1 day share price gain of 3.57%. However, the 30 day share price return is down 7% and the year to date share price return has fallen 16.84%. In contrast, the 3 year total shareholder return of 95.93% and 5 year...
Summary of Feb 10's posts. Generated by AI.
No summary yet.
No summary yet.
Investors talking about IRMD also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.